772 results on '"Collen, Désiré"'
Search Results
2. The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies
3. Long-Term Expression of Human Coagulation Factor VIII and Correction of Hemophilia A after in vivo Retroviral Gene Transfer in Factor VIII-Deficient Mice
4. Receptor-Independent Role of Urokinase-Type Plasminogen Activator in Pericellular Plasmin and Matrix Metalloproteinase Proteolysis during Vascular Wound Healing in Mice
5. Urokinase-Type Plasminogen Activator is Effective in Fibrin Clearance in the Absence of its Receptor or Tissue-Type Plasminogen Activator
6. Placental growth factor 2 — A potential therapeutic strategy for chronic myocardial ischemia
7. Biomedical applications of biotechnology
8. Vascular Endothelial Cell Function and Thrombosis
9. Role of the Plasminogen and MMP Systems in Wound Healing
10. Molecular and Cellular Angiogenesis
11. Tissue-type plasminogen activator: helping patients with acute myocardial infarction
12. F
13. Catheter-Mediated Delivery of Recombinant Adenovirus to the Vessel Wall to Inhibit Restenosis
14. Molecular Analysis of Vascular Development and Disorders
15. Role of Endothelial versus Smooth Muscle Cells in Blood Vessel Formation
16. Role of the Fibrinolytic and the Coagulation System in the Formation and Disorders of Blood Vessels
17. Staphylokinase: Biochemistry And Pharmacodynamics
18. Biological Effects of Targeted Gene Inactivation and Gene Transfer of the Coagulation and Fibrinolytic Systems in Mice
19. Regulation and Control of the Fibrinolytic System
20. Emerging treatments for thrombocytopenia: Increasing platelet production
21. A dose-finding clinical trial of staphylokinase SY162 in patients with long-term venous access catheter thrombotic occlusion
22. Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor
23. The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: Insights from genetic studies
24. Short-term delivery of anti-PlGF antibody delays progression of atherosclerotic plaques to vulnerable lesions
25. Pharmacology of fibrinolytic agents
26. Genetic evidence for a tumor suppressor role of HIF-2α
27. Role of Gas6 in erythropoiesis and anemia in mice
28. Current clinical experience with staphylokinase in arterial thrombosis
29. Pharmacology of thrombolytic agents
30. Impaired Adipose Tissue Development in Mice With Inactivation of Placental Growth Factor Function
31. Modulation of Angiogenesis during Adipose Tissue Development in Murine Models of Obesity
32. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy
33. Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors
34. Clot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen Activator
35. Clinical Gene Transfer Studies for Hemophilia A
36. Preclinical Gene Therapy Studies for Hemophilia Using Adenoviral Vectors
37. Onco-Retroviral and Lentiviral Vector-Based Gene Therapy for Hemophilia: Preclinical Studies
38. Clinical development of PEGylated recombinant staphylokinase (PEG–Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction
39. Heterozygous deficiency of hypoxia-inducible factor-2α protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia
40. Loss of the VEGF164 and VEGF188 Isoforms Impairs Postnatal Glomerular Angiogenesis and Renal Arteriogenesis in Mice
41. Modulation of Adipose Tissue Expression of Murine Matrix Metalloproteinases and Their Tissue Inhibitors With Obesity
42. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms
43. Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3)
44. Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells
45. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors
46. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE−/− mice
47. [12] Molecular interactions between tissue-type plasminogen activator and plasminogen
48. Vascular development and disorders: Molecular analysis and pathogenic insights
49. Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo
50. Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.